Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Infant formula GMPs

This article was originally published in The Tan Sheet

Executive Summary

Comment period on proposed infant formula GMPs and quality control procedures should be extended 60 days to Aug. 26, International Formula Council says in May 6 comments to FDA. Group is requesting extension "on behalf of all U.S. manufacturers of infant formula," noting "appropriateness of granting this extension is further underscored by the fact that only a few responders...are affected directly and their comments are anticipated to be comprehensive and in-depth and to require significant preparation time." FDA reopened comment period on the proposed rule, which was issued in 1996, in April (1"The Tan Sheet" May 5, 2003, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel